Clinical Trial Results: A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating finerenone with empagliflozin versus each monotherapy in adults with type 2 diabetes and chronic kidney disease; results completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)
• Finerenone (finerenone)

Snippet

Sponsor: Bayer | Conditions: Type 2 Diabetes Mellitus, Chronic Kidney Disease | Phase 2 | Status: COMPLETED | Results posted: 2026-07-13